A board-certified physician in internal medicine, hematology, and oncology with more than 25 years of experience, this expert holds a Doctor of Medicine (M.D.), a Master of Business Administration (M.B.A.), and a Bachelor of Arts (B.A.). He completed postgraduate training in internal medicine and hematology and oncology before beginning a career focused on the clinical management of cancer and blood disorders. He has held senior leadership roles including Chief of Hematology and Oncology and director of multiple cancer programs, where he oversaw clinical services, research initiatives, and palliative care programs. His work includes diagnosis and treatment of malignancies such as breast and lung cancer, along with expertise in cancer genetics, chemotherapy, and hematologic conditions, supported by involvement in clinical trials and published research.

In addition to clinical practice, he serves as President of a consulting organization providing case review, utilization analysis, reimbursement policy development, and guidance on FDA-related submissions and medical strategy. He has provided expert witness services in medical-legal matters, including case evaluations, depositions, and trial testimony involving oncology care, standards of care, wrongful death, and medical ethics. His expertise includes oncology treatment evaluation, clinical decision-making, healthcare policy, and analysis of medical practices in litigation contexts.